Pipeline / Therapeutic Platform / Remodulin®

Pre-filled system for subcutaneous administration of Remodulin® (treprostinil).

Implantable System for intravenous delivery of Remodulin® (treprostinil).

*FDA requires that certain conditions of Medtronic’s PMA approval of the Implantable System for Remodulin must be satisfied prior to launch or sale of the Implantable System for Remodulin; accordingly, Implantable System for Remodulin labeling may be revised in the process of satisfying such conditions of approval.

Prefilled, pre-programmed, single-use PatchPump® for subcutaneous administration of treprostinil.

Next-generation ambulatory micro-infusion pumps with smartphone compatibility.

Prodrug of treprostinil that is being developed to reduce site pain associated with subcutaneous delivery of treprostinil.